REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharm Abcine Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Pharm Abcine Inc. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharm Abcine Inc. is an enterprise based in South Korea. Its main office is in Daejeon. It operates in the Research and Development in Nanotechnology industry. It was first established on September 03, 2008. There are currently 39 (2024) people employed by Pharm Abcine Inc.. From the latest financial highlights, Pharm Abcine Inc. reported a net sales revenue increase of 1566.15% in Q3C2025. Its’ total assets recorded a growth of 20.15%.

Headquarters
2F, Yeongu 2-Dong, 70, Yuseong-Daero 1689Beon-Gil, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Pharm Abcine Inc. report to view the information.

Website: http://www.pharmabcine.com

Basic Information
Total Employees:
Purchase the Pharm Abcine Inc. report to view the information.
Outstanding Shares:
Purchase the Pharm Abcine Inc. report to view the information.
Registered Capital:
Purchase the Pharm Abcine Inc. report to view the information.
Financial Auditors:
Purchase the Pharm Abcine Inc. report to view the information.
Incorporation Date:
September 03, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
8.2%
Purchase this report to view the information.
6.8%
Purchase this report to view the information.
1.9%
Subsidiaries
(주)파멥신
Company Performance
Financial values in the chart are available after Pharm Abcine Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
1566.15%▲
Total Operating Revenue
957.03%▲
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
20.15%▲
Total Equity
12.05%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-4675.98%▼
Cash Ratio
-1.09%▼

Similar companies

Sk Biopharmaceuticals Co.,Ltd.
 
Ecopro Hn Co., Ltd.
Macrogen Inc.
 
Ligachem Biosciences Inc.
Dream Cis Inc.
 
C&R Research Inc.
Aptabio Therapeutics Inc.
 
CJ Bioscience, Inc.
Y-Biologics Inc.
 
Genomictree, Inc.
Calth. Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo